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Introduction ABCG2 (ATP binding cassette transporter isoform G2) exhibits a broad substrate specificity transporting hydrophobic, anionic, and cationic drugs (Mao and Unadkat, 2005) and widely distributes in such tissues as kidney, liver, blood-brain barrier, placenta, stem cells and mammary gland and is reported to be of relevance in the absorption, distribution, elimination and toxicity of drugs (Oostendorp et al., 2009 ). ABCG2 plays a significant role in the accumulation of xenobiotics in milk (Jonker et al., 2005; Merino et al., 2006) . Some dietary carcinogens, toxins and antibiotics that are substrates of ABCG2 are readily transported into milk and result in high M/S ratios van Herwaarden et al., 2006) . While other transporters may be present in lactating mammary epithelial cells ), ABCG2 appears to be playing a prominent role in drug accumulation in milk. One hypothesis would hold that all viable ABCG2 substrates would exhibit high M/S ratio (greater than diffusion alone).
Pantoprazole (PAN) is a proton pump (H+/K+-ATPase) inhibitor (PPI) that binds specifically and irreversibly to the proton pump to reduce gastric acid secretion (McDonagh et al., 2009) . PAN has been used as an inhibitor and a substrate of murine Bcrp1 (Breedveld et al., 2004) . A case report described a M/S value of 0.022 for racemic PAN. While the clinical relevance of this finding is not definitive, PAN use in lactating women was regarded as safe given the low infant dose exposure (Plante et al., 2004) . From a mechanistic perspective, the observation of such a low M/S ratio for an ABCG2 substrate is unclear and would appear to contradict the hypothesis that all such substrates would accumulate in milk. Perhaps PAN is not as good a substrate for human ABCG2 as was first thought and hence, diffusion and PAN extensive serum protein binding dominate the milk to serum ratio. Another confounding factor is that PAN is marketed as a racemate and the authors of the case report used did not measure This article has not been copyedited and formatted. The final version may differ from this version. DMD Fast Forward. Published on February 16, 2012 as DOI: 10.1124 at ASPET Journals on June 24, 2017 dmd.aspetjournals.org Downloaded from individual isomers. PAN has been shown to undergo enantioselective hepatic metabolism in both humans and rats (Tanaka et al., 2001; Xie et al., 2005) . Poor metabolizers of Smephenytoin (a CYP2C19 substrate) were less able to metabolize (+) PAN than (-) PAN (Tanaka et al., 2001) . A marked difference in the intereraction of PAN isomers with ABCG2 could be playing a role in its limited M/S ratio.
It is estimated that about half of marketed therapeutic agents are chiral with most available as 50/50 mixtures of their enantiomeric forms (Andersson and Weidolf, 2008) . The stereoselective metabolism as well as genetic polymorphisms of CYP450 and receptors can influence pharmacokinetics, pharmacodynamics, and toxicity (Katsuki et al., 2001; Tateishi et al., 2008; Miura and Uno) . These differentiated interactions may be especially critical for those drugs that have a narrow therapeutic index (e.g., warfarin). Remarkably, there are limited reports of stereoselective interaction of drugs with transporters. Cetirizine exhibited moderate enantioselectivity in the absorptive and secretory flux across CaCo-2 monolayers, which was attributed to the interaction of the enantiomers with P-gp and MRP2 (He et al., 2009) . Several in vitro and in vivo studies suggest an enantioselective drug transport at the human blood-brain barrier and implicate P-gp (Choong et al., 2010) . However, it should be noted that this is not universal observation. No evidence was observed for stereoselective P-gp mediated transport of S-and R-enantiomers of venlafaxine and its major metabolites into murine brain (Karlsson et al., 2010) . There are no reports of individual PAN isomers interacting with ABCG2 or any other transporter. There is but a single report of stereoselective drug accumulation in milk. The M/S ratio for the R enantiomers of fluoxetine (and its major metabolite, norfluoxetine) were 50% (40%) higher than the S enantiomers in lactating women (Kim et al., 2006) . The authors DMD #41608 6 speculated this stereoselective distribution into milk was attributed to differences in the extent of protein binding of the enantiomers in milk compared with plasma (Kim et al., 2006 ).
Previously we have utilized Abcg2 expressed in a MDCKII cell line and a chemical knockout Abcg2 rat model (Abcg2 inhibited by GF120918) to examine the role of Abcg2 in drug accumulation in milk (Wang et al., 2008) . The purpose of the current paper was to establish whether any stereoselective differences of PAN isomers with rAbcg2 are manifested in the accumulation of PAN isomers in rat milk. The observations made in the current paper prompted further detailed in vitro characterization of PAN flux in another companion paper (Wang et al., 2011 In vitro M/S. The contribution of passive diffusion on the M/S of PAN was estimated in vitro using Equation 1 (Fleishaker et al., 1987; Fleishaker and McNamara, 1988) :
where f u is the unionized fraction of drug in serum or milk, f is the free fraction of drug in serum or milk, W/S is the ratio of the drug concentration in whole milk to the drug concentration in skim milk, and the subscripts s and m represent serum and milk, respectively.
The W/S ratios, a measure of the partitioning of PAN isomers into milk fat, were determined following LC-MS analysis of PAN isomer concentrations in whole milk and skim milk into which isomer had been added. The unionized fraction in serum and skim milk, a measure of the pH partitioning of drug between serum and milk, was calculated from the pKa of each isomer and from the pH of serum (pH 7.45) and milk (pH 6.8) (approximately 0.15 ml) administered i.v. 10 minutes before an i.v. infusion of PAN in saline (0.4 mg/ml/h) for 8 h. All animals were crossed over on the second day to complete both phases of pretreatment (Wang et al., 2008) . One milliliter of normal saline was given hourly by i.v.
infusion to prevent dehydration during infusion. The dams were separated from the pups 4 hours before the infusion. Blood samples were drawn every 2 hours during the infusion. The blood samples were protected from light in separator tubes (BD Microtainer, Franklin Lakes, NJ), centrifuged to harvest serum, and frozen at -80°C until analysis. Milk samples were obtained by manual manipulation under light anesthesia (ketamine) at the end of the infusion. Milk samples were protected from light exposure, and frozen at -80°C until analysis.
Sample preparation for LC-MS.
To each aliquot (50 µl) of serum, 10 µl 0.2 M NaOH and 20 µl of 10 µg/ml zonisamide sodium (internal standard) were added and the proteins were precipitated with 1ml Ethyl acetate, vortexed for 1 min, and then centrifuged at 2,400 rpm for 15 min at room temperature. The clear layer was collected into another clean glass tube (~0.8 ml)
and dried under nitrogen in a 40 o C water bath. Samples were reconstituted in 50 μl mobile phase (15% Acetonitrille and 85% water but without formic acid). Each aliquot of 25 μl of milk was mixed with an equal volume of NaOH and zonisamide sodium. Protein was precipitated with 1 ml of cold methanol, vortexed for 30 seconds, and then centrifuged at 14,000g for 10 min at 4°C.
The clear layer was collected to a clean glass tube (~0.9ml) and dried under nitrogen in a 40°C
water bath. Samples were reconstituted in 200 µl water and mixed with 1 ml ethyl acetate was added. The extraction procedure was the same as serum samples. The collected clear layers were dried under nitrogen in a 40 o C water bath and reconstituted in 50 µl mobile phase. This method was adapted from Bharathi (Bharathi et al., 2009) . PAN isomers in phosphate buffer samples from in vitro predicted M/S ratio experiment were reconstituted in 1 ml water and 2 ml ethyl This article has not been copyedited and formatted. The final version may differ from this version. Pantoprazole HPLC analysis (in vitro studies). Concentrations of total PAN were assayed by HPLC on a Luna RP18 125 x 4.0-mm column (Phenomenex, Torrance, CA). The analyte was eluted with 40% acetonitrile/60% 10 mM potassium phosphate buffer, pH 7.2, at 0.5 ml/min.
PAN was detected by UV absorption (290 nm). Aliquots of PAN in Opti-MEM medium were directly injected onto the HPLC. The standard curve range was 7.8 to 2000 ng/ml. All the standard curves showed an intraday and interday variability of <10% and r 2 > 0.999. 1.51, respectively in Abcg2-MDCKII cell line. These stereoselective differences in initial rates were maintained as the profiles approached steady state of (+) and (-) PAN were 3.82 and 1.77 (p<0.01), respectively.
Pantoprazole isomer analyses by LC-MS (in vivo

Predicted M/S ratios of pantoprazole isomers. Table 1 contains individual parameter
estimates that contribute to the diffusion model prediction of M/S of the PAN isomers (Fleishaker et al., 1987) . The fraction of unionized approximated 1 for both PAN isomers since their pK a (3.9) was considerably lower than the pH of both rat milk and serum. The free fractions of PAN isomers were determined by equilibrium dialysis using serum concentrations obtained in rat infusion study. The serum free faction of (+) and (-) PAN were 2.33% and 2.38%, This article has not been copyedited and formatted. The final version may differ from this version. In vivo study-pantoprazole isomers accumulate in rat milk. The lactating rats were infused with racemic PAN and each isomer concentration in serum and milk were measured by LC-MS. Chromatographs of PAN isomers and zonisamide are shown in Figure 2 The mean PAN isomer concentration time profiles in serum and milk are shown in Figure 3 .
In the dosing vehicle treatment, both PAN isomers appeared to achieve steady-state serum concentrations after 2 hour time point in the intravenous infusion protocol with (-) PAN (1.63 μg/ml) slightly higher than (+) PAN (1,204 μg/ml). Pre-treatment with GF120918 increased the serum concentration of both PAN isomers, in particular for (-) PAN, which increased by 37%.
In the control group, (+) PAN (0.57±0.1) had greater systemic clearance (Figure 4 , panels A and B) than did (-) PAN (0.44±0.12). The two-way ANOVA indicated a significant isomer and treatment effect, but no interaction.
At 8 hours, PAN isomers were assumed to be at steady state and were distributed differently into milk in the rat. The milk concentration of (-) PAN (2.26±0.84 μg/ml) was considerably higher than (+) PAN (0.64±0.16 μg/ml). The milk concentrations were lower for both isomers 
Discussion
The current paper demonstrated that Abcg2 interacts stereoselectively with PAN isomers in both in vitro and in vivo studies which resulted in a differential accumulation of substrate isomers in milk. The M/S of (-) PAN was almost 3 times that of (+) PAN in control groups and the M/S of both isomers converged to a similar value following the administration of GF120918.
Since p-glycoprotein is not expressed in lactating rat epithelium (Wang et al., 2008) , this observation would indicate that Abcg2 contributes to PAN distribution in rat milk with Abcg2 serving as a major determinant for (-) PAN accumulation.
ABCG2 is a widely distributed efflux transporter and plays an important role in absorption, distribution, metabolism and excretion (ADME) of drugs and there is a growing concern regarding the role of ABCG2 in drug-drug interactions as well (Giacomini et al., 2010; Huang and Woodcock, 2010) . ABCG2 has been found on the apical surface of lactating mammary epithelial cells (Jonker et al., 2005 ) and a number of investigators have demonstrated the importance of this transporter in the accumulation of drugs in milk (Jonker et al., 2005; Perez et al., 2009 ). An overarching hypothesis would hold that ABCG2 substrates accumulate in milk, resulting in relatively high M/S ratios, greater than that predicted by simple diffusion.
A clinical case report of a low M/S for PAN (Plante et al., 2004) would appear to run counter to this hypothesis since PAN is thought of a good ABCG2 substrate (Breedveld et al., 2004) . The reason for the low M/S is unclear. PAN is highly protein bound (>98%) in human serum (Andersson and Weidolf, 2008) and rat serum (Xie et al., 2005) . Data in the current work confirms that the protein binding of both PAN isomers in rat serum is extensive and may play some role in mitigating the contribution of rAbcg2 related accumulation in milk. PAN has a modest octanol to water partitioning and hence, the milk fat partitioning is higher (reflected in a This article has not been copyedited and formatted. The final version may differ from this version. higher W/S value) than many drugs which should result in a higher M/S. The unionized fractions for the two isomers were assumed to be identical and were estimated to be very low and similar for skim milk and serum, hence no ion trapping influence on M/S. Therefore, the overall M/S ratios predicted by diffusion for both isomers were low and identical. The observed M/S in rat were 4.4 fold [(+) PAN] and 12.5 fold [(-) PAN] higher than predicted by diffusion, clearly suggesting a role of rAbcg2 in PAN accumulation in milk. The observed M/S ratios of (+) PAN and (-) PAN in the rat were 20-60 times higher than the M/S value reported for one lactating woman (Plante et al., 2004) . The explanation for the low human M/S remains unclear.
Our in vitro experiment demonstrated a rAbcg2 mediated, apically directed transport of PAN and indicated that PAN is a substrate of rAbcg2, which is consistent with the reports for human and mouse ABCG2/Abcg2 (Breedveld et al., 2004; Breedveld et al., 2005) . The flux of the (+) PAN was greater than the flux of the (-) PAN isomer at 25 μM ( Figure 1B) . Hence, one might conclude that the (+) PAN is a better substrate for rAbcg2 than (-) PAN which would contradict the in vivo M/S result. In order to rationalize this apparent contradiction, a more detailed in vitro experiment of PAN transport using a range of concentrations was performed (Wang et al., 2011) . These result suggests that the (-) PAN isomer is, in fact, the better ABCG2 substrate; possessing a greater affinity and overall apical efflux permeability (PS AE ) for rAbcg2.
The greater flux of (+) PAN ( Figure 1B ) arises due to the interplay between the two membranes (basolateral and apical) in determining the overall flux. At lower concentrations, PAN (both isomers) flux across the apical membrane (rAbcg2 mediated) is so rapid that the overall rate limiting step is diffusion across the basolateral membrane. At 25 µM concentration, (-) PAN isomer saturates rAbcg2 at the apical membrane, slowing its overall flux across the monolayer, This article has not been copyedited and formatted. The final version may differ from this version. leading to the appearance of a more rapid flux for (+) PAN (Figure 1) . A more comprehensive analysis is presented in companion paper (Wang et al., 2011) .
In the chemical Abcg2 knockout rat model, co-administration of GF120918 decreased the systemic clearance of nitrofurantoin (Wang et al., 2008) . In the present study, (-) PAN had a lower systemic clearance compared to (+) PAN and was consistent with the literature (Masubuchi et al., 1998) . The administration of GF120918 had a modest effect on PAN isomer systemic clearance, which would indicate that neither Abcg2 or p-glycoprotein (also inhibited by GF1200918) play a major role in the systemic clearance of PAN. The systemic clearance of PAN in humans, is largely determined by hepatic metabolism of PAN (Huber et al., 1996) .
Stereochemistry is an important aspect of biology and plays a role in many aspects of drug disposition (Bhatia et al., 2008 ) and yet there are few studies examining stereoselective transport of drugs (He et al., 2009; Choong et al., 2010) . PAN has been used as a competitive ABCG2
inhibitor to identify other ABCG2 substrates or to study drug-drug interaction. PAN is marketed as a racemic mixture whose stereoselective disposition has been characterized (Masubuchi et al., 1998; Tanaka et al., 2001 ). However, the interaction of its isomers with transporters (e.g., ABCG2) has not been described. This article has not been copyedited and formatted. The final version may differ from this version. 
